SCHEMBL801306

SCHEMBL801306

O=P(c1ccccc1)(c1cc2ccc3cccc4ccc(c1)c2c34)c1ccc2c(c1)c1ccccc1n2-c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.44
▸ ATM Q13315 1/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ NPSR1 Q6W5P4 1/20 0.37
▸ ERBB2 P04626 1/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ FYN P06241 1/20 0.34
▸ MAOA P21397 1/20 0.34
▸ ACHE P22303 1/20 0.34
▸ AHR P35869 1/20 0.34
▸ ALDH1A1 P00352 2/20 0.33
▸ TSHR P16473 2/20 0.33
▸ KMT2A Q03164 4/20 0.32
▸ MEN1 O00255 3/20 0.32
▸ JAK2 O60674 1/20 0.32
▸ JAK3 P52333 1/20 0.32
▸ POLB P06746 1/20 0.32
▸ BRCA1 P38398 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32
▸ MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL801485 0.98 KDM4E (0.41) KDM4EATML3MBTL1NPSR1ERBB2
SCHEMBL801197 0.94 NPSR1 (0.34) KDM4EATML3MBTL1NPSR1ERBB2
SCHEMBL801450 0.94 KDM4E (0.40) KDM4EATML3MBTL1NPSR1ERBB2
SCHEMBL801133 0.91 KDM4E (0.47) KDM4EATML3MBTL1NPSR1ALDH1A1
SCHEMBL801302 0.89 KDM4E (0.50) KDM4EATML3MBTL1NPSR1ALDH1A1
SCHEMBL801298 0.88 KDM4E (0.56) KDM4EATML3MBTL1NPSR1ALDH1A1
SCHEMBL801297 0.88 KDM4E (0.56) KDM4EATML3MBTL1NPSR1ALDH1A1
SCHEMBL30281357 0.88 KDM4E (0.56) KDM4EATML3MBTL1NPSR1ALDH1A1
SCHEMBL14923187 0.86 KDM4E (0.49) KDM4EATML3MBTL1NPSR1ALDH1A1
SCHEMBL14923169 0.86 KDM4E (0.49) KDM4EATML3MBTL1NPSR1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9278986-B2 Carbazole-based phosphine oxide compound, and organic electroluminescent device including the same SK CHEMICALS CO., LTD. (KR) 2016-03-08 — — US disclosed
US-9278986-B2 Carbazole-based phosphine oxide compound, and organic electroluminescent device including the same SK CHEMICALS CO., LTD. (KR) 2016-03-08 — — US disclosed
US-20120068168-A1 CARBAZOLE-BASED PHOSPHINE OXIDE COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME INDUSTRY-ACADEMIC COOPERATION FOUNDATION, DANKOOK UNIVERSITY (KR) 2012-03-22 — — US disclosed
US-20120068168-A1 CARBAZOLE-BASED PHOSPHINE OXIDE COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME INDUSTRY-ACADEMIC COOPERATION FOUNDATION, DANKOOK UNIVERSITY (KR) 2012-03-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120068168-A1 CARBAZOLE-BASED PHOSPHINE OXIDE COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME INPP5B, EZH2, PLCB3 KDM4E 1186/4885ATM 3758/4885L3MBTL1 1822/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback